Educational Tools for the Improvement of Early Advance Care Planning in Adolescents and Young Adults With Advanced Solid Tumors and High-Grade Brain Tumors
A Study of ASP3082 in Adults With Advanced Solid Tumors
for
Solid Tumor
Location: Boston MA, New Haven CT, New York NY, Hackensack NJ,
Sponsor: Astellas Pharma Inc
Sex: All
Age: 18+
Code: NCT05382559
Phase1, Recruiting
A First-in-human, Dose Escalation and Dose Expansion Study of SAR445877 in Adult Participants With Advanced Solid Tumors
for
Solid Tumor
Location: Providence RI, New York NY, Hackensack NJ, Newark DE,
Sponsor: Sanofi
Sex: All
Age: 18+
Code: NCT05584670
Phase1, Phase2, Recruiting
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
Get alerts for new trials in your area by subscribing now
JZP898 Intravenous Infusion as Monotherapy and Combination With Pembrolizumab in Adults With Advanced/Metastatic Solid Tumors
for
Advanced Solid Tumor, Metastatic Solid Tumor
Location: Philadelphia PA, Fairfax VA, Durham NC, Orlando FL,
Sponsor: Jazz Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06108050
Phase1, Recruiting
A Study of ASP1002 in Adults for Treatment of Solid Tumors
for
Advanced Solid Tumors
Location: Plainville CT, New Haven CT, New York NY, Fairfax VA,
Sponsor: Astellas Pharma Global Development, Inc.
Sex: All
Age: 18+
Code: NCT05719558
Phase1, Recruiting
JAB-2485 Activity in Adult Patients With Advanced Solid Tumors
for
Solid Tumors, ER+ Breast Cancer,
Location: Detroit MI, St Louis MO, Dallas TX, Salt Lake City UT
Sponsor: Jacobio Pharmaceuticals Co., Ltd.
Sex: All
Age: 18+
Code: NCT05490472
Phase1, Phase2, Recruiting
A Phase 1/2 Study of D3S-002 as Monotherapy or Combination Therapy in Adult Subjects With Advanced Solid Tumors With MAPK Pathway Mutations
for
Advanced Solid Tumors With MAPK Pathway Mutations
Location: Detroit MI, Nashville TN, Houston TX
Sponsor: D3 Bio (Wuxi) Co., Ltd
Sex: All
Age: 18+
Code: NCT05886920
Phase1, Phase2, Recruiting
A Study to Investigate the Pharmacokinetics and Safety of Subcutaneous Rilvegostomig in Adult Participants With Advanced Solid Tumors Previously Treated With Standard of Care Therapy
for
Advanced Solid Tumors
Location: Fairfax VA, Huntersville NC, San Antonio TX
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT07161414
Phase1, Recruiting
JAB-23E73 in Adult Participants With Advanced Solid Tumors With KRAS Alteration
for
Advanced Solid Tumors
Location: Cleveland OH, St Louis MO, Rochester MN,
Sponsor: Jacobio Pharmaceuticals Co., Ltd.
Sex: All
Age: 18+
Code: NCT06973564
Phase1, Phase2, Recruiting
A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors
for
ER+, HER 2- Breast Cancer, Non-small Cell Lung Cancer (NSCLC),
Location: Lake Success NY, East Brunswick NJ, Fairfax VA,
Sponsor: IDEAYA Biosciences
Sex: All
Age: 18 - 70+
Code: NCT07540572
Phase1, Recruiting
First Time in Human (FTIH) Study to Investigate the Safety and Preliminary Activity of GSK5533524 Alone or in Combination in Adult Participants With Advanced Solid Tumors
for
Neoplasms
Location: Toronto, Montreal, Philadelphia PA, San Antonio TX
Sponsor: GlaxoSmithKline
Sex: All
Age: 18+
Code: NCT07438782
Phase1, Recruiting
Immunotherapy For Adults With GPC3-Positive Solid Tumors Using IL-15 and IL-21 Armored GPC3-CAR T Cells